LTR Pharma (ASX:LTP) Other Income (Expense) : A$0.41 Mil (TTM As of Dec. 2024)

View and export this data going back to 2023. Start your Free Trial

What is LTR Pharma Other Income (Expense)?

LTR Pharma's other income expense for the LTR Pharma's pretax income for the six months ended in Dec. 2024 was A$0.37 Mil. Its other income expense for the trailing twelve months (TTM) ended in Dec. 2024 was A$0.41 Mil.

LTR Pharma Other Income (Expense) Historical Data

The historical data trend for LTR Pharma's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LTR Pharma Other Income (Expense) Chart

LTR Pharma Annual Data

Trend

Jun21

Jun22

Jun23

Jun24

Other Income (Expense)

-0.02

0.04

LTR Pharma Semi-Annual Data
	Jun21	Jun22	Jun23	Dec23	Jun24	Dec24
Other Income (Expense)	Get a 7-Day Free Trial			-	-	-	0.04	0.37

LTR Pharma Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$0.41 Mil.

LTR Pharma (ASX:LTP) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.

LTR Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » LTR Pharma Ltd (ASX:LTP) » Definitions » Other Income (Expense)

Comparable Companies

Traded in Other Exchanges

N/A

Address

9A/204 Alice Street, Brisbane, QLD, AUS, 4000

Website

https://www.ltrpharma.com

LTR Pharma Ltd is a clinical stage pharmaceutical company focused on holistically improving men's health, physically and mentally, through the commercialization of an intranasal spray treatment for Erectile Dysfunction. SPONTAN is a Vardenafil-based nasal delivery formulation designed to be a lower dose fast-acting administration that provides a rapid and high availability to a patient's bloodstream compared with the incumbent oral ED treatment products on the market.

LTR Pharma Headlines

No Headlines